BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 6452968)

  • 1. [From the search for a lymphocytic chalone to the rediscovery of serum thymic factor (FTS)].
    Lenfant M; Millerioux L; Duchange N; Tanzer J
    C R Seances Acad Sci III; 1981 Feb; 292(5):403-5. PubMed ID: 6452968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New insight into lymphocytic chalone research. The 'facteur thymique Sérique' might be responsible for part of the immunosuppressive activity detected in the 'chalone fraction'.
    Lenfant M; Millerioux L
    Int Arch Allergy Appl Immunol; 1982; 68(4):387-91. PubMed ID: 6212552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of facteur thymique sérique (FTS) in the thymus. II. Direct demonstration of the presence of FTS in thymosin fraction V.
    Dardenne M; Pléau JM; Blouquit JY; Bach JF
    Clin Exp Immunol; 1980 Dec; 42(3):477-82. PubMed ID: 7011613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A factor regulating thymus activity].
    Antonenko VT; Lissova ZI
    Vrach Delo; 1982 Jun; (6):25-8. PubMed ID: 7202292
    [No Abstract]   [Full Text] [Related]  

  • 5. [Studies on thymic peptide factors. III. Isolation, purification, biochemical property and E-rosette activity in vitro of porcine thymic factors].
    Cui LX; Xu CS; Tao K; Yang GZ; Liu SL; Zheng CX
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1984 Jun; 6(3):170-3. PubMed ID: 6241041
    [No Abstract]   [Full Text] [Related]  

  • 6. Activation of polyclonal antibody responses by a synthetic serum thymic factor (FTS) in CBA/N mice.
    Matsumoto T; Shibata M
    Immunology; 1982 Feb; 45(2):293-301. PubMed ID: 7037618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Modification of the antigenicity of the serum thymic factor (thymulin) by zinc].
    Pleau JM; Dardenne M; Bach JF
    C R Seances Acad Sci III; 1981 May; 292(17):991-3. PubMed ID: 6791774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thymic hormone containing cells. III. Evidence for a feed-back regulation of the secretion of the serum thymic factor (FTS) by thymic epithelial cells.
    Savino W; Dardenne M; Bach JF
    Clin Exp Immunol; 1983 Apr; 52(1):7-12. PubMed ID: 6683135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between a spleen-derived immunosuppressive peptide 'SDIP' and the 'Facteur thymique sérique' (FTS): biochemical and biological comparison of the two factors.
    Lenfant M; Millerioux L; Blazsek I; Duchange N
    Immunology; 1983 Apr; 48(4):635-45. PubMed ID: 6682089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extraction from bovine spleen of immunosuppressant with no activity on hematopoietic spleen colony formation.
    Garcia-Giralt E; Rella W; Morales VH; Diaz-Rubio E; Richaud F
    Natl Cancer Inst Monogr; 1973 Jul; 38():125-9. PubMed ID: 4148201
    [No Abstract]   [Full Text] [Related]  

  • 11. Biological and clinical properties of THF.
    Trainin N; Handzel ZT; Pecht M
    Thymus; 1985; 7(3):137-50. PubMed ID: 3875914
    [No Abstract]   [Full Text] [Related]  

  • 12. [Refractoriness of mouse spleen rosette-forming cells to thymus hormones during the period of early postnatal ontogeny].
    Giulling EV; Nikol'skiĭ IS; Kravchuk GP; Ovsienko VV; Khaloimova IL
    Ontogenez; 1981; 12(1):100-2. PubMed ID: 7197341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radioimmunoassay of serum thymic factor (FTS).
    Ikeyama S; Kato K; Takaoki M; Takeuchi M; Kakinuma A
    J Immunoassay; 1984; 5(1-2):87-97. PubMed ID: 6538886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Role of zinc and other metals in the biological activity of the serum thymic factor (thymulin)].
    Dardenne M; Pleau JM; Lefrancier P; Bach JF
    C R Seances Acad Sci III; 1981 Mar; 292(13):793-6. PubMed ID: 6791843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of facteur thymique sérique (FTS) in the thymus. I. Fixation of anti-FTS antibodies on thymic reticulo-epithelial cells.
    Monier JC; Dardenne M; Pléau JM; Schmitt D; Deschaux P; Bach JF
    Clin Exp Immunol; 1980 Dec; 42(3):470-6. PubMed ID: 7011612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence of the presence in normal serum of a carrier of the serum thymic factor (FTS).
    Dardenne M; Pléau JM; Bach JF
    Eur J Immunol; 1980 Feb; 10(2):83-6. PubMed ID: 7189463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating thymic hormone activity in young cancer patients.
    Consolini R; Cei B; Cini P; Bottone E; Casarosa L
    Clin Exp Immunol; 1986 Oct; 66(1):173-80. PubMed ID: 3802571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Thymic factors influence on melatonin-producing pineal function in mice of different age: the possible mechanisms].
    Labunets IF
    Adv Gerontol; 2007; 20(1):86-91. PubMed ID: 17969591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro induction of monoclonal antibody-defined T-cell markers in lymphocytes from immunodeficient children by synthetic serum thymic factor (FTS).
    Bene MC; Faure G; Bordigoni P; Olive D; Duheille J
    Clin Exp Immunol; 1982 May; 48(2):423-8. PubMed ID: 7049454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunosuppressive action in vitro by a bovine spleen extract.
    Morales VH; Garcia-Giralt E
    Z Naturforsch B; 1971 Dec; 26(12):1339-40. PubMed ID: 4401889
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.